Narayana Hrudayalaya Share Price Jumps 3% As Kotak Securities Upgrades To 'Buy': Check Target Price

Shares of Narayana Hrudayalaya Ltd. rose nearly 3% on Monay, Aug. 24 after fomestic brokerage firm Kotak Securities has upgraded its rating on healthcare provider' stock to 'Buy' from 'Add', raising its target price to Rs 2,350 per share from the earlier Rs 2,220. The brokerage highlighted that market concerns surrounding the healthcare company's insurance initiatives are overblown, while its core hospital business continues to demonstrate robust operational momentum at attractive valuations.

On Monday, shares of Narayana Hrudayalaya opened at Rs 1,840 against its previous close of Rs 1,815.80 and extended the positive momentum by upo 3% to hit an intraday high of Rs 1,876 apiece on the NSE. The stock last traded 2.43% higher at Rs 1,860 apiece on the NSE. This compares to a drop of 0.26% in the Nifty 50 benchmark. The stock has shed 5% in one month, 4% on a year-to-date basis, but is up 3% in one year. The company commands a market cap of Rs 38,009.07 crore.

ALSO READ: Sugar Stocks Resume Rally; Shree Renuka Sugars, Bajaj Hindusthan Sugar Zoom Up To 12%

Narayana Hrudayalaya Share Price Intraday

Kotak Securities upgrades Narayana Hrudayalaya

The brokerage's upgrade is underpinned by strong fundamentals in Narayana Hrudayalaya's domestic hospital operations.

• Robust EBITDA Growth: The core India hospital segment delivered a strong 39% year-on-year (YoY) EBITDA growth, reflecting resilient patient volumes, operational efficiencies, and superior cost management.
• Compelling Valuation: According to Kotak Securities, the standalone India hospital portfolio is currently trading at attractive valuations, presenting a favorable risk-reward profile for long-term investors.
   

Easing Drag From Integrated Care, Domestic Insurance

Analysts believe that investor concerns regarding the gestation losses in the domestic integrated care and health insurance ventures appear overextended for the company. Kotak Securities expects that operating losses from the Indian integrated care business to taper off gradually from the near-term as network density and patient onboarding mature.

ALSO READ: Jewellery Stocks Shine Brighter: Senco Gold, PC Jeweller Share Price Jump Upto 4% - Here's Why
 

Improving International Dynamics: Cayman & UK

According to Kotak Securities, the key catalysts for Narayana Hrudayalaya's growth prospects are price hikes absorption in Cayman, narrowing integrated care losses, and UK margin expansion. Cayman insurance breakeven is expected by the end of FY28. The brokerage highlighted positive triggers across the company's overseas operations:

• Cayman Insurance Turnaround: Following strong market acceptance of recent price increases, losses in the Cayman Islands insurance vertical are expected to decline at an accelerated pace. Kotak projects the Cayman insurance business to achieve EBITDA breakeven by the end of FY28.
• Expanding UK Margins: Margins in the United Kingdom operations are poised for expansion, supported by better capacity utilization and optimized cost structures.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.